Novartis drug Zortress® is first in over a decade approved by FDA to prevent organ rejection in adult liver transplant patients
15 February 2013 | By Novartis
The FDA has approved Zortress®...
List view / Grid view
15 February 2013 | By Novartis
The FDA has approved Zortress®...
15 February 2013 | By GlaxoSmithKline
The FDA has granted a priority review designation to dolutegravir...
14 February 2013 | By Teva Pharmaceutical Industries Ltd
TEVA announced that the U.S. FDA has approved its Abbreviated New Drug Application (ANDA)...
29 January 2013 | By Boehringer Ingelheim
Olodaterol may provide a new treatment option in patients with COPD...
28 January 2013 | By Sanofi
Genzyme also reports very encouraging early launch indicators for AUBAGIO® (teriflunomide) in U.S.
24 January 2013 | By Roche
Roche announced that the US FDA approved a new use of Avastin...
16 January 2013 | By Biogen Idec
Biogen Idec and Elan have submitted applications to the U.S. FDA...
14 January 2013 | By GlaxoSmithKline
Albiglutide is not yet approved as a treatment for type 2 diabetes...
3 January 2013 | By Abbott
FDA approval - XIENCE Xpedition™ Everolimus Eluting Coronary Stent System...
31 December 2012 | By Johnson & Johnson
FDA has granted accelerated approval to SIRTURO™ Tablets for the treatment of pulmonary multi-drug resistant tuberculosis...
22 December 2012 | By Roche
First medicine approved to treat influenza in infants two weeks of age and older...
20 November 2012 | By Novartis
The US FDA approved the use of Flucelvax®...
19 November 2012 | By GlaxoSmithKline
GlaxoSmithKline plc announced that the U.S. FDA has approved PROMACTA for the treatment of thrombocytopenia...
14 November 2012 | By GlaxoSmithKline
“GSK has been collaborating with the U.S. Department of Health and Human Services..."
9 November 2012 | By Novo Nordisk
“The positive vote from the Advisory Committee marks an important step..."